In its Series B funding round, Valeo Health, a trailblazing leader in AI-driven healthcare, raised $12 million, bringing its total funding to $20 million. Valeo Health, which was co-founded by Sundeep Sahni, Nadine Karadag, and Ankur Majumder, is revolutionizing data-driven, individualized healthcare in the area. In addition to new investors Oraseya and Eirad, the round was led by Flintera and included participation from previous investors Nuwa Capital, FJ Labs, Oryx, and Mindshift Capital. Personalized, scientifically supported healthcare solutions will be more widely available in the Kingdom of Saudi Arabia, the United Arab Emirates, and the rest of the Gulf Cooperation Council (GCC) thanks to the investment.
This funding round strengthens the increasing trust in Valeo Health’s creative approach to at-home healthcare powered by AI. The most recent investment comes after Valeo’s successful at-home healthcare services, customized treatment plans based on each patient’s needs, and its exclusive Longevity technology.
“We are thrilled by the strong investor support as we continue to redefine how people engage with their health,” said Sundeep Sahni, CEO & Co-Founder of Valeo Health. “This funding enables us to scale our AI technology, enhance our product offerings, and expand our reach, ensuring more individuals benefit from proactive healthcare solutions.” Co-founder Nadine Karadag added, “This investment validates our team’s hard work and strengthens our ability to scale personalised healthcare across the region.”
“Valeo is not just building another health-tech platform — it’s shaping the future of preventive care in the region. At Flintera, we back founders who merge cutting-edge technology with clear, scalable vision, and Sundeep and his team embody exactly that. HealthTech is one of our key investment priorities, and we’re excited that our first investment in the region is with such a strong, mission-driven company. We’re also deeply committed to bringing the best technologies to the region and look forward to supporting more exceptional entrepreneurs and sustainable business models across the GCC.”
“We first backed Valeo in 2021, drawn by the strength of the founding team and a clear opportunity to address a real market need. Since then, Sundeep, Nadine and Ankur have delivered with focus and consistency, building an integrated platform with strong cross-border potential and impressive year-over-year growth. A key to their success has been providing customers with real benefits across multiple touchpoints and associated journeys. With this round, we have the opportunity to deepen the customer centricity and provide even more value to our most important stakeholder. We’re excited to continue supporting Valeo as they scale and take the business to the next stage.” – Nitin Reen, Partner at Nuwa Capital
As a well-known brand in the health technology sector in the KSA and UAE, Valeo Health is dedicated to providing people with personalized wellness and health solutions and real-time insights. The company will be able to further transform the future of individualized healthcare by expanding its reach regionally thanks to the funding.
